Experts working across oncology are exploring how different treatment approaches can work together to improve outcomes for ...
Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes Eric Schmidt.
Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development ...
SAN DIEGO and CALGARY, AB, Feb. 19, 2025 /PRNewswire/ — Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to ...
Purple Biotech Ltd. announced it is advancing NT219, a novel drug aimed at overcoming tumor resistance to therapy, into a Phase 2 clinical trial for patients with recurrent/metastatic squamous cell ...
Once upon a time, Moderna was a shooting star whose success relied on the COVID-19 vaccine, but now advances in an RSV vaccine could mean more success for the pharmaceutical and biotechnology company.
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of ...
Moleculin Biotech, Inc. has announced progress regarding its drug Annamycin, designed to eliminate the cardiotoxicity often associated with anthracyclines used in cancer treatments, especially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results